RVPH icon

Reviva Pharmaceuticals

36 hedge funds and large institutions have $27.1M invested in Reviva Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+12
Holders Change %
+50%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
14
Reduced
3
Closed
3
Calls
$3.48M
Puts
$3.48M
Net Calls
+$9K
Net Calls Change
+$732K
Name Holding Trade Value Shares
Change
Shares
Change %
BCM
26
BluePointe Capital Management
California
$53.4K +$53.4K +10,378 New
IWC
27
Integrated Wealth Concepts
Massachusetts
$51.5K +$51.5K +10,000 New
Morgan Stanley
28
Morgan Stanley
New York
$49.1K +$46.5K +9,035 +1,803%
Northwestern Mutual Wealth Management
29
Northwestern Mutual Wealth Management
Wisconsin
$47.9K
WAM
30
Wolverine Asset Management
Illinois
$23.9K -$48.2K -9,351 -67%
Belvedere Trading
31
Belvedere Trading
Illinois
$17.1K -$238K -46,181 -93%
CG
32
Cutler Group
California
$15K +$7.11K +1,443 +90%
JPMorgan Chase & Co
33
JPMorgan Chase & Co
New York
$4.72K +$4.72K +917 New
AIC
34
Archer Investment Corporation
Indiana
$2.58K
Wells Fargo
35
Wells Fargo
California
$716 -$25.7K -4,993 -97%
Group One Trading
36
Group One Trading
Illinois
-$631K -129,301 Closed
GCP
37
GSA Capital Partners
United Kingdom
-$342K -70,181 Closed
SM
38
Sabby Management
Florida
-$218K -44,593 Closed